COLUMBUS, OHIO – As lawmakers are finishing up their legislative session, they continue to think about 71,850 Ohioans who will hear the words “you have cancer” this year.
The U.S. Senate passed legislation tonight aimed at improving access to clinical trials for communities of color and decreasing health disparities.
A companion to a House bill introduced in the Senate today aims to improve access to new and innovative cancer screenings among Medicare beneficiaries in order to increase early detection of more cancers for more Americans.
The 31 undersigned organizations, representing millions of patients and consumers across the country who face serious, acute, and chronic health conditions, applaud Congressional committee leaders for reaching a bicameral and bipartisan agreement to address surprise medical billing and urge Congress to quickly enact it.
CHARLESTON, W. Va. – As lawmakers were finishing up the legislative session this past spring, they continued to think about 12,380 West Virginians who will hear the words “you have cancer” this year.
More than a dozen patient groups representing millions of Americans with serious and chronic health conditions are urging the U.S. District Court for the Southern District of New York to preserve protections in the Affordable Care Act (ACA) for lesbian, gay, bisexual, transgender and queer (LGBTQ) patients receiving health care
The U.S. House of Representatives is expected to pass legislation today aimed at improving access to clinical trials for communities of color and decreasing health disparities.
he U.S. House of Representatives passed the Removing Barriers to Colorectal Cancer Screening Act unanimously today.
Washington, D.C. —The Trump administration issued a interim final rule Friday that would significantly change how Medicare pays for certain prescription drugs.
As millions of seniors and other enrollees select their 2021 Medicare health benefits during annual open enrollment, a new report details just how confusing the program’s appeals process can be should a patient need to appeal a claim denial for health care services or prescription drugs.